Image
9:00 AM to 4:00 PM | September 21, 2022

Annual U-M Drug Discovery Symposium

Rackham Graduate School, 915 E. Washington Street, Ann Arbor
Audience This is a public event.
The second Annual U-M Drug Discovery Symposium aims to highlight success stories from the drug discovery community at the University of Michigan. The symposium will give faculty and trainees a chance to share best practices and network with others involved with drug discovery research on campus.

Schedule 

Research talks are 50 minutes, plus a 10-minute Q&A session

  • 9:00 a.m. Coffee gathering
    Assembly Hall, 4th floor, Rackham Graduate School
  • 9:20 a.m. Symposium welcome
    Peter Toogood, Ph.D.

    Director, Michigan Drug Discovery
    Amphitheater, 4th floor, Rackham Graduate School
  • 9:30 a.m. Research talk: Targeting hyperactivated-EGFR for cancer therapy including for mt-KRAS or mt-BRAF positive cancers
    Mukesh Nyati, Ph.D.
    Professor of Radiation Oncology, U-M Medical School
    Amphitheater, 4th floor, Rackham Graduate School
  • 10:30 a.m. Research talk: Targeting DOT1L and MLL-oncofusion protein-protein interactions as a novel therapeutic strategy
    Zaneta Nikolovska-Coleska, Ph.D.
    Professor of Pathology, U-M Medical School
    Amphitheater, 4th floor, Rackham Graduate School
  • 11:30 a.m. Coffee break
    Assembly Hall, 4th floor, Rackham Graduate School
  • 11:45 a.m. Research talk: From concept to clinic: The discovery and development of eliglustat tartrate for Gaucher disease James Shayman, M.D.
    Agnes C and Frank D McKay Professor, Professor of Pharmacology and Professor of Internal Medicine, U-M Medical School
    Amphitheater, 4th floor, Rackham Graduate School
  • 12:45 a.m. Networking poster session
    Assembly Hall, 4th floor, Rackham Graduate School
  • 2:00 p.m. Research talk: We are explorers in radiochemical space: Adventures in radiochemistry, artificial intelligence and radiotheranostics
    Peter Scott, Ph.D.
    Associate Professor of Radiology and Associate Professor of Pharmacology, U-M Medical School 
    Amphitheater, 4th floor, Rackham Graduate School
  • 3:00 p.m. Keynote presentation: Inhibitors of HIV-1 maturation
    Nicholas Meanwell, Ph.D.
    Scientific Vice President, Bristol Myers Squibb
    Amphitheater, 4th floor, Rackham Graduate School
  • 4:00 p.m. Closing remarks
    Peter Toogood

    Amphitheater, 4th floor, Rackham Graduate School